Skip to Content

ER 414 (Pramipexole Dihydrochloride Extended-Release 3.75 mg)

Pill with imprint ER 414 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 3.75 mg. It is supplied by Alembic Pharmaceuticals Inc..

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 3.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 414

Pramipexole Dihydrochloride Extended-Release

Imprint
ER 414
Strength
3.75 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0160

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.